All News | Regulatory

CONTROLLED SUBSTANCES NEWS

Sep 2, 2019
Texas Pharmacies, Medical Professionals Charged in Connection With Pill Mills
Aug 26, 2019
DEA to Propose New Rules for Marijuana Grower Program; Publishes List of Applicants
Aug 25, 2019
DEA Proposes Removal of 6-beta-Naltrexol From Control
Aug 11, 2019
New York Doctor Pleads Guilty to CSA Violations, Identity Theft
Aug 4, 2019
DEA Must Explain Slow Response on Petition to Manufacture Cannabis
Jul 23, 2019
Six ‘Designer’ Drugs to Schedule I
Jul 21, 2019
Registrant Miami-Luken, Two Corporate Officials and Two Pharmacists Charged With Conspiracy
Jul 7, 2019
New York Doctor Sentenced to Five Years, Must Forfeit $1.4M
Jun 30, 2019
Pennsylvania Doctor Indicted for Subsys Bribes, Kickbacks
Jun 25, 2019
Alabama Doctor Pleads Guilty; PDMP Showed High Number of Prescriptions for Controlled Substances
Jun 20, 2019
Three Marketed Drugs Scheduled Under Expedited Procedures
Jun 13, 2019
DEA Asks Congress for Permanent Class-Wide Scheduling Authority for Fentanyl
Jun 10, 2019
DEA Searches Rite Aid Pharmacies in Ohio
May 29, 2019
Opioid Distributor Will Pay $22M and Upgrade Compliance Program Under DOJ Settlement
May 19, 2019
Industry Asks for Clarification on Proposed Form 222 Process
May 12, 2019
O’Callaghan Is Acting Deputy AG Pending Replacement of Rosenstein
May 5, 2019
Six Synthetic Cathinones in Line for Temporary Schedule I Control
Apr 30, 2019
Hearing Rules Changed to Allow Review of ALJ Denial of Interlocutory Appeal
Apr 23, 2019
Rochester Drug Co-Operative, Former Executives Indicted for Unlawful Distribution of Opioids
Apr 22, 2019
DEA Publishes Chemical Names of Previously Controlled Fentanyl-Related Substances
Apr 16, 2019
Rulemaking to Control Six Synthetic Cannabinoids Continues
Apr 15, 2019
CDC Report Identifies Kratom in Overdose Deaths
Apr 1, 2019
Priorities Not Changing at DOJ, New AG Says
Mar 25, 2019
Georgia Medical Professionals Caught for Diversion of Opioids
Mar 5, 2019
Connecticut Physician Loses Registration Over Improper Prescribing for Patients and Family

Copyright © Thompson Controlled Subtances, a division of CBIS. All rights reserved.